Abstract
In order to search for many target compounds with excellent activities, a series of 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluoro-phenyl)-3-[(4-substituted phenyl)-piperazin-1-yl]-propan-2-ols were designed, synthesized, and evaluated as antifungal agents. Results of preliminary antifungal tests against eight human pathogenic fungi in vitro showed that all the title compounds exhibited excellent activities with broad spectrum. Moreover, a molecular model for the binding between 5a and the active site of CACYP51 was provided based on the computational docking results.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
14-alpha Demethylase Inhibitors / chemical synthesis
-
14-alpha Demethylase Inhibitors / chemistry*
-
14-alpha Demethylase Inhibitors / pharmacology*
-
Antifungal Agents / chemical synthesis
-
Antifungal Agents / chemistry*
-
Antifungal Agents / pharmacology*
-
Azoles / chemical synthesis
-
Azoles / chemistry*
-
Azoles / pharmacology*
-
Fungi / drug effects*
-
Fungi / enzymology
-
Humans
-
Microbial Sensitivity Tests
-
Models, Molecular
-
Mycoses / drug therapy
-
Protein Binding
-
Sterol 14-Demethylase / chemistry
-
Sterol 14-Demethylase / metabolism
-
Structure-Activity Relationship
Substances
-
14-alpha Demethylase Inhibitors
-
Antifungal Agents
-
Azoles
-
Sterol 14-Demethylase